Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.

The #PrEP4All campaign made the call for affordable pre-exposure prophylaxis a national news story.

Advocates say the price is a step in the right direction. But does it go far enough?

But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.

We answer some key questions about the latest new effort to kill the Affordable Care Act, including what it means for people living with HIV and what can do to make a difference.

In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.

Activist Mark Hannay explains what the bill means for people living with HIV and how it will shape the 2020 election debate.

Drug pricing expert Tim Horn helps us make sense of the administration's future plans for the Medicare Part D and 340B programs.

In order to adequately address the HIV epidemic in the United States, two advocates argue that the high cost of antiretroviral drugs must be addressed.

The activists have big plans for using their techniques to pressure the new Congress into inching toward universal health care in the years ahead.